Investigational Drug Information for Fallypride
✉ Email this page to a colleague
What is the development status for investigational drug Fallypride?
Fallypride is an investigational drug.
There have been 18 clinical trials for Fallypride.
The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2005.
The most common disease conditions in clinical trials are Schizophrenia, Obesity, and Alcoholism. The leading clinical trial sponsors are University of California, Irvine, Vanderbilt University Medical Center, and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Summary for Fallypride
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 19 |
| WIPO Patent Applications | 23 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2005-04-01) |
| Vendors | 18 |
Recent Clinical Trials for Fallypride
| Title | Sponsor | Phase |
|---|---|---|
| Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 | National Institute on Drug Abuse (NIDA) | Phase 3 |
| Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 | Emory University | Phase 3 |
| Dopaminergic Dysfunction in Late-Life Depression | Columbia University | Phase 2 |
Clinical Trial Summary for Fallypride
Top disease conditions for Fallypride
Top clinical trial sponsors for Fallypride
US Patents for Fallypride
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
